Vivo Bio Tech (BOM:511509) EV-to-FCF: (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:511509 Vivo Bio Tech Ltd BOM:511509
63 GF Score
Price ₹25.19
GF Value ₹29.40
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Vivo Bio Tech EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Vivo Bio Tech's Enterprise Value is ₹1,218.4 Mil. Vivo Bio Tech's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0.0 Mil. Therefore, Vivo Bio Tech's EV-to-FCF for today is .

The historical rank and industry rank for Vivo Bio Tech's EV-to-FCF or its related term are showing as below:

BOM:511509' s EV-to-FCF Range Over the Past 10 Years
Min: -48.61   Med: 0   Max: 0
Current: -48.61

BOM:511509's EV-to-FCF is ranked worse than
100% of 335 companies
in the Biotechnology industry
Industry Median: 15.34 vs BOM:511509: -48.61

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-14), Vivo Bio Tech's stock price is ₹25.19. Vivo Bio Tech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ₹-1.430. Therefore, Vivo Bio Tech's PE Ratio (TTM) for today is At Loss.


Vivo Bio Tech  (BOM:511509) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Vivo Bio Tech's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=25.19/-1.430
=At Loss

Vivo Bio Tech's share price for today is ₹25.19.
Vivo Bio Tech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-1.430.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Vivo Bio Tech EV-to-FCF Related Terms


Vivo Bio Tech EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Vivo Bio Tech's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivo Bio Tech EV-to-FCF Chart

Vivo Bio Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.55 8.29 17.90 -10.64 -44.94

Vivo Bio Tech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -44.94 0.00

BOM:511509 vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, Vivo Bio Tech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivo Bio Tech EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Vivo Bio Tech's EV-to-FCF falls into.


BOM:511509
63GF Score
Vivo Bio Tech Ltd BOM:511509
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivo Bio Tech EV-to-FCF Calculation

Vivo Bio Tech's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1218.432/0
=

Vivo Bio Tech's current Enterprise Value is ₹1,218.4 Mil.
Vivo Bio Tech's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?

Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued. The current stock price of ₹25.19 is trading 14.3% below its estimated GF Value™ of ₹29.40. GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.

Key valuation signals for BOM:511509:

  • EV-to-FCF:
  • GF Value™: ₹29.40 vs. price of ₹25.19 (14.3% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vivo Bio Tech Business Description

Address Number 8-2-672/ 5 & 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
63GF Score

Get the complete analysis for BOM:511509

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹25.19
Price
₹29.40
GF Value